Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
Clinical trial NCT00189956 · COMPLETED
Trial details
- NCT number
- NCT00189956
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2003-11-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.